Bioartificial Organ Manufacturing Market Share Statistics Report,Size, Forecast, & Trends

Data Bridge Market Research analyses that the bioartificial organ manufacturing market which was USD 23.13 billion in 2022, is expected to reach USD 42.03 billion by 2030, at a CAGR of 7.75% during the forecast period 2023 to 2030.

"To win the competition in the global market, choosing a reliable Bioartificial Organ Manufacturing Market  research report is very important. Businesses can gain insight into a complete industry background analysis that includes home market assessment. This market report takes into account the various market analysis segments demanded by today's businesses. Clients are used to a great combination of the best industry insights, practical solutions, talent solutions and the latest technology when using Bioartificial Organ Manufacturing Market reports for business growth. Market drivers and restraints have been explained here using SWOT analysis.

The key areas covered in the best Bioartificial Organ Manufacturing Market report include market definition, market segmentation, competitive analysis, and research methodology. Additionally, to better understand facts and figures, data is presented in the form of graphs, tables, and charts. This market research report is the definitive solution to have exclusive market research data that anticipates business needs. Apart from that, business people can find out the extent of market problems, the reasons for the failure of certain products already on the market, and the market prospects for new products that will be launched.

Data Bridge Market Research analyses that the bioartificial organ manufacturing market which was USD 23.13 billion in 2022, is expected to reach USD 42.03 billion by 2030, at a CAGR of 7.75% during the forecast period 2023 to 2030.

Explore Further Details about This Research Bioartificial Organ Manufacturing Market Report https://www.databridgemarketresearch.com/reports/global-bioartificial-organ-manufacturing-market

Bioartificial Organ Manufacturing Market Scope and Segmentation  

REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Degree of Automation (Semi-Automated, Fully Automated, Handworked), Materials (Mechanical, Biomechanical, Biological), Process (Architectural Predesign, Preparation of Materials and Construction Tools, Homogeneous/Heterogeneous Cell Assembling, Post Multi-Tissue Maturation)

Countries Covered

U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

B. Braun SE (Germany), Boston Scientific Corporation (U.S.), Getinge AB. (Sweden), ABIOMED. (U.S.), Asahi Kasei Corporation (Japan), Berlin Heart (Germany), CARMAT (France), Jarvik Heart, Inc. (U.S.), Terumo Corporation (Japan), SynCardia Systems, LLC (U.S.), Nipro Europe Group Companies (Japan), Medtronic (U.S.), Organovo Holdings Inc. (U.S.), NexImmune (U.S.), Diabeloop SA (France), Admetsys (U.S.), Defymed (France), Pancreum, Inc. (U.S.), Beta Bionics Inc. (U.S.), Integra LifeSciences (U.S.)

Market Opportunities

  • Advances in 3D bio-printing
  • Increased product launches

Market Definition

Bioartificial organ manufacturing technologies are a series of enabling techniques that can produce human organs based on bionic principles. Organ manufacturing technologies can be divided into three main groups: (1) fully automated, (2) semi-automated, and (3) handworked (or handmade). One of the most promising bioartificial organ manufacturing technologies is combining multi-nozzle three-dimensional printing techniques to assemble personal cells and other biomaterials to build exclusive organ substitutes for defective/failed human organs.

Global Bioartificial Organ Manufacturing Market Dynamics

Drivers

• Increased RD activities

Factors such as increased product launches increased RD activities, and key market players' strategies will drive the growth of the studied segment. Furthermore, the segment's growth is expected to be fuelled by new product approvals and ongoing government support. In February 2020, the U.S. Food and Drug Administration (FDA) granted Abbott Breakthrough Device designation for its in-development fully implantable left ventricular assist system. In March 2021, Penn State Health Milton S. Hershey Medical Center became the country's second hospital to implant a newly designed EvaHeart2 Left Ventricular Assist System (LVAS) in a patient with severe heart failure. These all are certain factors that propel the growth of the market.

• Increasing prevalence of organ failure

The rising prevalence of organ failure caused by severe infections, cardiovascular disease, and trauma increases the number of organ transplant surgeries. In 2019, the World Health Organization reported approximately 48.9 million cases of sepsis. Adopting bad habits like drinking and smoking leads to liver and heart failure. As the prevalence of such illnesses rises, so does the risk of organ failure, driving up demand for bioartificial organs.

Opportunities

• Advances in 3D bioprinting

Advances in 3D bioprinting have proven critical in organ transplantation because it is used to create artificial organs. 3D bioprinting is becoming increasingly popular because it reduces the risk of organ rejection. Furthermore, artificial intelligence is poised to alter global trends in artificial device usage. Many countries are currently focusing on a tool that provides a personalized assessment of organ and donor suitability. This tool will be extremely helpful in making informed decisions about organ retrieval and determining whether patients should accept donor organs or wait for better options.

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2022)
  • Past Pricing and price curve by region (2018 to 2022)
  • Market Size, Share, Size Forecast by different segment | 2023−2029
  • Bioartificial Organ Manufacturing Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
  • Market Segmentation – A detailed analysis by segment with their sub-segments and Region
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective
  • Competitive landscape – Market Leaders, Market Followers, Regional player
  • Competitive benchmarking of key players by region
  • PESTLE Analysis
  • PORTER’s analysis
  • Value chain and supply chain analysis
  • Legal Aspects of Business by Region
  • Lucrative business opportunities with SWOT analysis
  • Recommendations

Browse Related Reports: 

Medical Printers Market Size, Share, Growth Analysis

root beer market Size, Share, Growth

Soap Dispenser Market Size, Share Trends: Report

Hereditary Sensory Motor Neuropathy Market Size, Share, Industry, Forecast

Airway Management Tubes Market Size, Share Trends [Report]

Polyethylene Terephthalate (PET) Foam Market Share Statistics Report,Size, Forecast, Trends

PPG (Photoplethysmography) Biosensors Market Size, Global Industry Share, Recent

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com

"


pratik Patil

218 Blog posts

Comments